Global and United States MedroxyProgesterone Market Size, Status and Forecast 2021-2027
SKU ID :QYR-19208976 | Published Date: 23-Sep-2021 | No. of pages: 129Description
TOC
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global MedroxyProgesterone Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Injection
1.2.3 Tablets
1.2.4 Capsule
1.2.5 Long-Acting Injection (Powder)
1.2.6 Cycloprogesterone Oil Injection
1.2.7 Medroxyprogesterone Silicone Rubber Vaginal Ring
1.3 Market by Application
1.3.1 Global MedroxyProgesterone Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Kidney Cancer
1.3.3 Breast Cancer
1.3.4 Endometrial Cancer
1.3.5 Prostate Cancer
1.3.6 Long-Acting Contraception
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global MedroxyProgesterone Market Perspective (2016-2027)
2.2 MedroxyProgesterone Growth Trends by Regions
2.2.1 MedroxyProgesterone Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 MedroxyProgesterone Historic Market Share by Regions (2016-2021)
2.2.3 MedroxyProgesterone Forecasted Market Size by Regions (2022-2027)
2.3 MedroxyProgesterone Industry Dynamic
2.3.1 MedroxyProgesterone Market Trends
2.3.2 MedroxyProgesterone Market Drivers
2.3.3 MedroxyProgesterone Market Challenges
2.3.4 MedroxyProgesterone Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top MedroxyProgesterone Players by Revenue
3.1.1 Global Top MedroxyProgesterone Players by Revenue (2016-2021)
3.1.2 Global MedroxyProgesterone Revenue Market Share by Players (2016-2021)
3.2 Global MedroxyProgesterone Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by MedroxyProgesterone Revenue
3.4 Global MedroxyProgesterone Market Concentration Ratio
3.4.1 Global MedroxyProgesterone Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by MedroxyProgesterone Revenue in 2020
3.5 MedroxyProgesterone Key Players Head office and Area Served
3.6 Key Players MedroxyProgesterone Product Solution and Service
3.7 Date of Enter into MedroxyProgesterone Market
3.8 Mergers & Acquisitions, Expansion Plans
4 MedroxyProgesterone Breakdown Data by Type
4.1 Global MedroxyProgesterone Historic Market Size by Type (2016-2021)
4.2 Global MedroxyProgesterone Forecasted Market Size by Type (2022-2027)
5 MedroxyProgesterone Breakdown Data by Application
5.1 Global MedroxyProgesterone Historic Market Size by Application (2016-2021)
5.2 Global MedroxyProgesterone Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America MedroxyProgesterone Market Size (2016-2027)
6.2 North America MedroxyProgesterone Market Size by Type
6.2.1 North America MedroxyProgesterone Market Size by Type (2016-2021)
6.2.2 North America MedroxyProgesterone Market Size by Type (2022-2027)
6.2.3 North America MedroxyProgesterone Market Size by Type (2016-2027)
6.3 North America MedroxyProgesterone Market Size by Application
6.3.1 North America MedroxyProgesterone Market Size by Application (2016-2021)
6.3.2 North America MedroxyProgesterone Market Size by Application (2022-2027)
6.3.3 North America MedroxyProgesterone Market Size by Application (2016-2027)
6.4 North America MedroxyProgesterone Market Size by Country
6.4.1 North America MedroxyProgesterone Market Size by Country (2016-2021)
6.4.2 North America MedroxyProgesterone Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe MedroxyProgesterone Market Size (2016-2027)
7.2 Europe MedroxyProgesterone Market Size by Type
7.2.1 Europe MedroxyProgesterone Market Size by Type (2016-2021)
7.2.2 Europe MedroxyProgesterone Market Size by Type (2022-2027)
7.2.3 Europe MedroxyProgesterone Market Size by Type (2016-2027)
7.3 Europe MedroxyProgesterone Market Size by Application
7.3.1 Europe MedroxyProgesterone Market Size by Application (2016-2021)
7.3.2 Europe MedroxyProgesterone Market Size by Application (2022-2027)
7.3.3 Europe MedroxyProgesterone Market Size by Application (2016-2027)
7.4 Europe MedroxyProgesterone Market Size by Country
7.4.1 Europe MedroxyProgesterone Market Size by Country (2016-2021)
7.4.2 Europe MedroxyProgesterone Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific MedroxyProgesterone Market Size (2016-2027)
8.2 Asia-Pacific MedroxyProgesterone Market Size by Type
8.2.1 Asia-Pacific MedroxyProgesterone Market Size by Type (2016-2021)
8.2.2 Asia-Pacific MedroxyProgesterone Market Size by Type (2022-2027)
8.2.3 Asia-Pacific MedroxyProgesterone Market Size by Type (2016-2027)
8.3 Asia-Pacific MedroxyProgesterone Market Size by Application
8.3.1 Asia-Pacific MedroxyProgesterone Market Size by Application (2016-2021)
8.3.2 Asia-Pacific MedroxyProgesterone Market Size by Application (2022-2027)
8.3.3 Asia-Pacific MedroxyProgesterone Market Size by Application (2016-2027)
8.4 Asia-Pacific MedroxyProgesterone Market Size by Region
8.4.1 Asia-Pacific MedroxyProgesterone Market Size by Region (2016-2021)
8.4.2 Asia-Pacific MedroxyProgesterone Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America MedroxyProgesterone Market Size (2016-2027)
9.2 Latin America MedroxyProgesterone Market Size by Type
9.2.1 Latin America MedroxyProgesterone Market Size by Type (2016-2021)
9.2.2 Latin America MedroxyProgesterone Market Size by Type (2022-2027)
9.2.3 Latin America MedroxyProgesterone Market Size by Type (2016-2027)
9.3 Latin America MedroxyProgesterone Market Size by Application
9.3.1 Latin America MedroxyProgesterone Market Size by Application (2016-2021)
9.3.2 Latin America MedroxyProgesterone Market Size by Application (2022-2027)
9.3.3 Latin America MedroxyProgesterone Market Size by Application (2016-2027)
9.4 Latin America MedroxyProgesterone Market Size by Country
9.4.1 Latin America MedroxyProgesterone Market Size by Country (2016-2021)
9.4.2 Latin America MedroxyProgesterone Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa MedroxyProgesterone Market Size (2016-2027)
10.2 Middle East & Africa MedroxyProgesterone Market Size by Type
10.2.1 Middle East & Africa MedroxyProgesterone Market Size by Type (2016-2021)
10.2.2 Middle East & Africa MedroxyProgesterone Market Size by Type (2022-2027)
10.2.3 Middle East & Africa MedroxyProgesterone Market Size by Type (2016-2027)
10.3 Middle East & Africa MedroxyProgesterone Market Size by Application
10.3.1 Middle East & Africa MedroxyProgesterone Market Size by Application (2016-2021)
10.3.2 Middle East & Africa MedroxyProgesterone Market Size by Application (2022-2027)
10.3.3 Middle East & Africa MedroxyProgesterone Market Size by Application (2016-2027)
10.4 Middle East & Africa MedroxyProgesterone Market Size by Country
10.4.1 Middle East & Africa MedroxyProgesterone Market Size by Country (2016-2021)
10.4.2 Middle East & Africa MedroxyProgesterone Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Carlo Erba
11.1.1 Carlo Erba Company Details
11.1.2 Carlo Erba Business Overview
11.1.3 Carlo Erba MedroxyProgesterone Introduction
11.1.4 Carlo Erba Revenue in MedroxyProgesterone Business (2016-2021)
11.1.5 Carlo Erba Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer MedroxyProgesterone Introduction
11.2.4 Pfizer Revenue in MedroxyProgesterone Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 Polichem
11.3.1 Polichem Company Details
11.3.2 Polichem Business Overview
11.3.3 Polichem MedroxyProgesterone Introduction
11.3.4 Polichem Revenue in MedroxyProgesterone Business (2016-2021)
11.3.5 Polichem Recent Development
11.4 Nanjing Chengong Pharmaceutical
11.4.1 Nanjing Chengong Pharmaceutical Company Details
11.4.2 Nanjing Chengong Pharmaceutical Business Overview
11.4.3 Nanjing Chengong Pharmaceutical MedroxyProgesterone Introduction
11.4.4 Nanjing Chengong Pharmaceutical Revenue in MedroxyProgesterone Business (2016-2021)
11.4.5 Nanjing Chengong Pharmaceutical Recent Development
11.5 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
11.5.1 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Company Details
11.5.2 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Business Overview
11.5.3 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) MedroxyProgesterone Introduction
11.5.4 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Revenue in MedroxyProgesterone Business (2016-2021)
11.5.5 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Recent Development
11.6 Beijing Yimin Pharmaceutical
11.6.1 Beijing Yimin Pharmaceutical Company Details
11.6.2 Beijing Yimin Pharmaceutical Business Overview
11.6.3 Beijing Yimin Pharmaceutical MedroxyProgesterone Introduction
11.6.4 Beijing Yimin Pharmaceutical Revenue in MedroxyProgesterone Business (2016-2021)
11.6.5 Beijing Yimin Pharmaceutical Recent Development
11.7 Guangzhou Kanghe Pharmaceutical
11.7.1 Guangzhou Kanghe Pharmaceutical Company Details
11.7.2 Guangzhou Kanghe Pharmaceutical Business Overview
11.7.3 Guangzhou Kanghe Pharmaceutical MedroxyProgesterone Introduction
11.7.4 Guangzhou Kanghe Pharmaceutical Revenue in MedroxyProgesterone Business (2016-2021)
11.7.5 Guangzhou Kanghe Pharmaceutical Recent Development
11.8 Zhejiang Xianju Pharmaceutical
11.8.1 Zhejiang Xianju Pharmaceutical Company Details
11.8.2 Zhejiang Xianju Pharmaceutical Business Overview
11.8.3 Zhejiang Xianju Pharmaceutical MedroxyProgesterone Introduction
11.8.4 Zhejiang Xianju Pharmaceutical Revenue in MedroxyProgesterone Business (2016-2021)
11.8.5 Zhejiang Xianju Pharmaceutical Recent Development
11.9 Beijing Kangbide Pharmaceutical
11.9.1 Beijing Kangbide Pharmaceutical Company Details
11.9.2 Beijing Kangbide Pharmaceutical Business Overview
11.9.3 Beijing Kangbide Pharmaceutical MedroxyProgesterone Introduction
11.9.4 Beijing Kangbide Pharmaceutical Revenue in MedroxyProgesterone Business (2016-2021)
11.9.5 Beijing Kangbide Pharmaceutical Recent Development
11.10 Harbin Outi Pharmaceutical
11.10.1 Harbin Outi Pharmaceutical Company Details
11.10.2 Harbin Outi Pharmaceutical Business Overview
11.10.3 Harbin Outi Pharmaceutical MedroxyProgesterone Introduction
11.10.4 Harbin Outi Pharmaceutical Revenue in MedroxyProgesterone Business (2016-2021)
11.10.5 Harbin Outi Pharmaceutical Recent Development
11.11 Hong Kong Aomei Pharmaceutical Factory
11.11.1 Hong Kong Aomei Pharmaceutical Factory Company Details
11.11.2 Hong Kong Aomei Pharmaceutical Factory Business Overview
11.11.3 Hong Kong Aomei Pharmaceutical Factory MedroxyProgesterone Introduction
11.11.4 Hong Kong Aomei Pharmaceutical Factory Revenue in MedroxyProgesterone Business (2016-2021)
11.11.5 Hong Kong Aomei Pharmaceutical Factory Recent Development
11.12 Jiangxi Zezhong Pharmaceutical
11.12.1 Jiangxi Zezhong Pharmaceutical Company Details
11.12.2 Jiangxi Zezhong Pharmaceutical Business Overview
11.12.3 Jiangxi Zezhong Pharmaceutical MedroxyProgesterone Introduction
11.12.4 Jiangxi Zezhong Pharmaceutical Revenue in MedroxyProgesterone Business (2016-2021)
11.12.5 Jiangxi Zezhong Pharmaceutical Recent Development
11.13 Nanjing Housheng Pharmaceutical
11.13.1 Nanjing Housheng Pharmaceutical Company Details
11.13.2 Nanjing Housheng Pharmaceutical Business Overview
11.13.3 Nanjing Housheng Pharmaceutical MedroxyProgesterone Introduction
11.13.4 Nanjing Housheng Pharmaceutical Revenue in MedroxyProgesterone Business (2016-2021)
11.13.5 Nanjing Housheng Pharmaceutical Recent Development
11.14 Yantai Luyin Pharmaceutical
11.14.1 Yantai Luyin Pharmaceutical Company Details
11.14.2 Yantai Luyin Pharmaceutical Business Overview
11.14.3 Yantai Luyin Pharmaceutical MedroxyProgesterone Introduction
11.14.4 Yantai Luyin Pharmaceutical Revenue in MedroxyProgesterone Business (2016-2021)
11.14.5 Yantai Luyin Pharmaceutical Recent Development
11.15 Beijing Langyi Pharmaceutical
11.15.1 Beijing Langyi Pharmaceutical Company Details
11.15.2 Beijing Langyi Pharmaceutical Business Overview
11.15.3 Beijing Langyi Pharmaceutical MedroxyProgesterone Introduction
11.15.4 Beijing Langyi Pharmaceutical Revenue in MedroxyProgesterone Business (2016-2021)
11.15.5 Beijing Langyi Pharmaceutical Recent Development
11.16 Sinopharm group
11.16.1 Sinopharm group Company Details
11.16.2 Sinopharm group Business Overview
11.16.3 Sinopharm group MedroxyProgesterone Introduction
11.16.4 Sinopharm group Revenue in MedroxyProgesterone Business (2016-2021)
11.16.5 Sinopharm group Recent Development
11.17 Chuankang Pharmaceutical
11.17.1 Chuankang Pharmaceutical Company Details
11.17.2 Chuankang Pharmaceutical Business Overview
11.17.3 Chuankang Pharmaceutical MedroxyProgesterone Introduction
11.17.4 Chuankang Pharmaceutical Revenue in MedroxyProgesterone Business (2016-2021)
11.17.5 Chuankang Pharmaceutical Recent Development
11.18 GMP
11.18.1 GMP Company Details
11.18.2 GMP Business Overview
11.18.3 GMP MedroxyProgesterone Introduction
11.18.4 GMP Revenue in MedroxyProgesterone Business (2016-2021)
11.18.5 GMP Recent Development
11.18 Hubei Gedian Renfu Pharmaceutical
.1 Hubei Gedian Renfu Pharmaceutical Company Details
.2 Hubei Gedian Renfu Pharmaceutical Business Overview
.3 Hubei Gedian Renfu Pharmaceutical MedroxyProgesterone Introduction
.4 Hubei Gedian Renfu Pharmaceutical Revenue in MedroxyProgesterone Business (2016-2021)
.5 Hubei Gedian Renfu Pharmaceutical Recent Development
11.20 Shanghai Xinhualian Pharmaceutical
11.20.1 Shanghai Xinhualian Pharmaceutical Company Details
11.20.2 Shanghai Xinhualian Pharmaceutical Business Overview
11.20.3 Shanghai Xinhualian Pharmaceutical MedroxyProgesterone Introduction
11.20.4 Shanghai Xinhualian Pharmaceutical Revenue in MedroxyProgesterone Business (2016-2021)
11.20.5 Shanghai Xinhualian Pharmaceutical Recent Development
11.21 China Resources Zizhu Pharmaceutical
11.21.1 China Resources Zizhu Pharmaceutical Company Details
11.21.2 China Resources Zizhu Pharmaceutical Business Overview
11.21.3 China Resources Zizhu Pharmaceutical MedroxyProgesterone Introduction
11.21.4 China Resources Zizhu Pharmaceutical Revenue in MedroxyProgesterone Business (2016-2021)
11.21.5 China Resources Zizhu Pharmaceutical Recent Development
11.22 Guangzhou Langsheng Pharmaceutical
11.22.1 Guangzhou Langsheng Pharmaceutical Company Details
11.22.2 Guangzhou Langsheng Pharmaceutical Business Overview
11.22.3 Guangzhou Langsheng Pharmaceutical MedroxyProgesterone Introduction
11.22.4 Guangzhou Langsheng Pharmaceutical Revenue in MedroxyProgesterone Business (2016-2021)
11.22.5 Guangzhou Langsheng Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Tables & Figures
List of Tables
Table 1. Global MedroxyProgesterone Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Injection
Table 3. Key Players of Tablets
Table 4. Key Players of Capsule
Table 5. Key Players of Long-Acting Injection (Powder)
Table 6. Key Players of Cycloprogesterone Oil Injection
Table 7. Key Players of Medroxyprogesterone Silicone Rubber Vaginal Ring
Table 8. Global MedroxyProgesterone Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global MedroxyProgesterone Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global MedroxyProgesterone Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global MedroxyProgesterone Market Share by Regions (2016-2021)
Table 12. Global MedroxyProgesterone Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global MedroxyProgesterone Market Share by Regions (2022-2027)
Table 14. MedroxyProgesterone Market Trends
Table 15. MedroxyProgesterone Market Drivers
Table 16. MedroxyProgesterone Market Challenges
Table 17. MedroxyProgesterone Market Restraints
Table 18. Global MedroxyProgesterone Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global MedroxyProgesterone Market Share by Players (2016-2021)
Table 20. Global Top MedroxyProgesterone Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in MedroxyProgesterone as of 2020)
Table 21. Ranking of Global Top MedroxyProgesterone Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by MedroxyProgesterone Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players MedroxyProgesterone Product Solution and Service
Table 25. Date of Enter into MedroxyProgesterone Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global MedroxyProgesterone Market Size by Type (2016-2021) (US$ Million)
Table 28. Global MedroxyProgesterone Revenue Market Share by Type (2016-2021)
Table 29. Global MedroxyProgesterone Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global MedroxyProgesterone Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global MedroxyProgesterone Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global MedroxyProgesterone Revenue Market Share by Application (2016-2021)
Table 33. Global MedroxyProgesterone Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global MedroxyProgesterone Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America MedroxyProgesterone Market Size by Type (2016-2021) (US$ Million)
Table 36. North America MedroxyProgesterone Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America MedroxyProgesterone Market Size by Application (2016-2021) (US$ Million)
Table 38. North America MedroxyProgesterone Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America MedroxyProgesterone Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America MedroxyProgesterone Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe MedroxyProgesterone Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe MedroxyProgesterone Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe MedroxyProgesterone Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe MedroxyProgesterone Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe MedroxyProgesterone Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe MedroxyProgesterone Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific MedroxyProgesterone Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific MedroxyProgesterone Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific MedroxyProgesterone Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific MedroxyProgesterone Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific MedroxyProgesterone Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific MedroxyProgesterone Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America MedroxyProgesterone Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America MedroxyProgesterone Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America MedroxyProgesterone Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America MedroxyProgesterone Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America MedroxyProgesterone Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America MedroxyProgesterone Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa MedroxyProgesterone Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa MedroxyProgesterone Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa MedroxyProgesterone Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa MedroxyProgesterone Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa MedroxyProgesterone Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa MedroxyProgesterone Market Size by Country (2022-2027) & (US$ Million)
Table 65. Carlo Erba Company Details
Table 66. Carlo Erba Business Overview
Table 67. Carlo Erba MedroxyProgesterone Product
Table 68. Carlo Erba Revenue in MedroxyProgesterone Business (2016-2021) & (US$ Million)
Table 69. Carlo Erba Recent Development
Table 70. Pfizer Company Details
Table 71. Pfizer Business Overview
Table 72. Pfizer MedroxyProgesterone Product
Table 73. Pfizer Revenue in MedroxyProgesterone Business (2016-2021) & (US$ Million)
Table 74. Pfizer Recent Development
Table 75. Polichem Company Details
Table 76. Polichem Business Overview
Table 77. Polichem MedroxyProgesterone Product
Table 78. Polichem Revenue in MedroxyProgesterone Business (2016-2021) & (US$ Million)
Table 79. Polichem Recent Development
Table 80. Nanjing Chengong Pharmaceutical Company Details
Table 81. Nanjing Chengong Pharmaceutical Business Overview
Table 82. Nanjing Chengong Pharmaceutical MedroxyProgesterone Product
Table 83. Nanjing Chengong Pharmaceutical Revenue in MedroxyProgesterone Business (2016-2021) & (US$ Million)
Table 84. Nanjing Chengong Pharmaceutical Recent Development
Table 85. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Company Details
Table 86. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Business Overview
Table 87. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) MedroxyProgesterone Product
Table 88. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Revenue in MedroxyProgesterone Business (2016-2021) & (US$ Million)
Table 89. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Recent Development
Table 90. Beijing Yimin Pharmaceutical Company Details
Table 91. Beijing Yimin Pharmaceutical Business Overview
Table 92. Beijing Yimin Pharmaceutical MedroxyProgesterone Product
Table 93. Beijing Yimin Pharmaceutical Revenue in MedroxyProgesterone Business (2016-2021) & (US$ Million)
Table 94. Beijing Yimin Pharmaceutical Recent Development
Table 95. Guangzhou Kanghe Pharmaceutical Company Details
Table 96. Guangzhou Kanghe Pharmaceutical Business Overview
Table 97. Guangzhou Kanghe Pharmaceutical MedroxyProgesterone Product
Table 98. Guangzhou Kanghe Pharmaceutical Revenue in MedroxyProgesterone Business (2016-2021) & (US$ Million)
Table 99. Guangzhou Kanghe Pharmaceutical Recent Development
Table 100. Zhejiang Xianju Pharmaceutical Company Details
Table 101. Zhejiang Xianju Pharmaceutical Business Overview
Table 102. Zhejiang Xianju Pharmaceutical Revenue in MedroxyProgesterone Business (2016-2021) & (US$ Million)
Table 103. Zhejiang Xianju Pharmaceutical Recent Development
Table 104. Beijing Kangbide Pharmaceutical Company Details
Table 105. Beijing Kangbide Pharmaceutical Business Overview
Table 106. Beijing Kangbide Pharmaceutical MedroxyProgesterone Product
Table 107. Beijing Kangbide Pharmaceutical Revenue in MedroxyProgesterone Business (2016-2021) & (US$ Million)
Table 108. Beijing Kangbide Pharmaceutical Recent Development
Table 109. Harbin Outi Pharmaceutical Company Details
Table 110. Harbin Outi Pharmaceutical Business Overview
Table 111. Harbin Outi Pharmaceutical MedroxyProgesterone Product
Table 112. Harbin Outi Pharmaceutical Revenue in MedroxyProgesterone Business (2016-2021) & (US$ Million)
Table 113. Harbin Outi Pharmaceutical Recent Development
Table 114. Hong Kong Aomei Pharmaceutical Factory Company Details
Table 115. Hong Kong Aomei Pharmaceutical Factory Business Overview
Table 116. Hong Kong Aomei Pharmaceutical Factory MedroxyProgesterone Product
Table 117. Hong Kong Aomei Pharmaceutical Factory Revenue in MedroxyProgesterone Business (2016-2021) & (US$ Million)
Table 118. Hong Kong Aomei Pharmaceutical Factory Recent Development
Table 119. Jiangxi Zezhong Pharmaceutical Company Details
Table 120. Jiangxi Zezhong Pharmaceutical Business Overview
Table 121. Jiangxi Zezhong Pharmaceutical MedroxyProgesterone Product
Table 122. Jiangxi Zezhong Pharmaceutical Revenue in MedroxyProgesterone Business (2016-2021) & (US$ Million)
Table 123. Jiangxi Zezhong Pharmaceutical Recent Development
Table 124. Nanjing Housheng Pharmaceutical Company Details
Table 125. Nanjing Housheng Pharmaceutical Business Overview
Table 126. Nanjing Housheng Pharmaceutical MedroxyProgesterone Product
Table 127. Nanjing Housheng Pharmaceutical Revenue in MedroxyProgesterone Business (2016-2021) & (US$ Million)
Table 128. Nanjing Housheng Pharmaceutical Recent Development
Table 129. Yantai Luyin Pharmaceutical Company Details
Table 130. Yantai Luyin Pharmaceutical Business Overview
Table 131. Yantai Luyin Pharmaceutical MedroxyProgesterone Product
Table 132. Yantai Luyin Pharmaceutical Revenue in MedroxyProgesterone Business (2016-2021) & (US$ Million)
Table 133. Yantai Luyin Pharmaceutical Recent Development
Table 134. Beijing Langyi Pharmaceutical Company Details
Table 135. Beijing Langyi Pharmaceutical Business Overview
Table 136. Beijing Langyi Pharmaceutical MedroxyProgesterone Product
Table 137. Beijing Langyi Pharmaceutical Revenue in MedroxyProgesterone Business (2016-2021) & (US$ Million)
Table 138. Beijing Langyi Pharmaceutical Recent Development
Table 139. Sinopharm group Company Details
Table 140. Sinopharm group Business Overview
Table 141. Sinopharm group MedroxyProgesterone Product
Table 142. Sinopharm group Revenue in MedroxyProgesterone Business (2016-2021) & (US$ Million)
Table 143. Sinopharm group Recent Development
Table 144. Chuankang Pharmaceutical Company Details
Table 145. Chuankang Pharmaceutical Business Overview
Table 146. Chuankang Pharmaceutical MedroxyProgesterone Product
Table 147. Chuankang Pharmaceutical Revenue in MedroxyProgesterone Business (2016-2021) & (US$ Million)
Table 148. Chuankang Pharmaceutical Recent Development
Table 149. GMP Company Details
Table 150. GMP Business Overview
Table 151. GMP MedroxyProgesterone Product
Table 152. GMP Revenue in MedroxyProgesterone Business (2016-2021) & (US$ Million)
Table 153. GMP Recent Development
Table 154. Hubei Gedian Renfu Pharmaceutical Company Details
Table 155. Hubei Gedian Renfu Pharmaceutical Business Overview
Table 156. Hubei Gedian Renfu Pharmaceutical MedroxyProgesterone Product
Table 157. Hubei Gedian Renfu Pharmaceutical Revenue in MedroxyProgesterone Business (2016-2021) & (US$ Million)
Table 158. Hubei Gedian Renfu Pharmaceutical Recent Development
Table 159. Shanghai Xinhualian Pharmaceutical Company Details
Table 160. Shanghai Xinhualian Pharmaceutical Business Overview
Table 161. Shanghai Xinhualian Pharmaceutical MedroxyProgesterone Product
Table 162. Shanghai Xinhualian Pharmaceutical Revenue in MedroxyProgesterone Business (2016-2021) & (US$ Million)
Table 163. Shanghai Xinhualian Pharmaceutical Recent Development
Table 164. China Resources Zizhu Pharmaceutical Company Details
Table 165. China Resources Zizhu Pharmaceutical Business Overview
Table 166. China Resources Zizhu Pharmaceutical MedroxyProgesterone Product
Table 167. China Resources Zizhu Pharmaceutical Revenue in MedroxyProgesterone Business (2016-2021) & (US$ Million)
Table 168. China Resources Zizhu Pharmaceutical Recent Development
Table 169. Guangzhou Langsheng Pharmaceutical Company Details
Table 170. Guangzhou Langsheng Pharmaceutical Business Overview
Table 171. Guangzhou Langsheng Pharmaceutical MedroxyProgesterone Product
Table 172. Guangzhou Langsheng Pharmaceutical Revenue in MedroxyProgesterone Business (2016-2021) & (US$ Million)
Table 173. Guangzhou Langsheng Pharmaceutical Recent Development
Table 174. Research Programs/Design for This Report
Table 175. Key Data Information from Secondary Sources
Table 176. Key Data Information from Primary Sources
List of Figures
Figure 1. Global MedroxyProgesterone Market Share by Type: 2020 VS 2027
Figure 2. Injection Features
Figure 3. Tablets Features
Figure 4. Capsule Features
Figure 5. Long-Acting Injection (Powder) Features
Figure 6. Cycloprogesterone Oil Injection Features
Figure 7. Medroxyprogesterone Silicone Rubber Vaginal Ring Features
Figure 8. Global MedroxyProgesterone Market Share by Application: 2020 VS 2027
Figure 9. Kidney Cancer Case Studies
Figure 10. Breast Cancer Case Studies
Figure 11. Endometrial Cancer Case Studies
Figure 12. Prostate Cancer Case Studies
Figure 13. Long-Acting Contraception Case Studies
Figure 14. MedroxyProgesterone Report Years Considered
Figure 15. Global MedroxyProgesterone Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global MedroxyProgesterone Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global MedroxyProgesterone Market Share by Regions: 2020 VS 2027
Figure 18. Global MedroxyProgesterone Market Share by Regions (2022-2027)
Figure 19. Global MedroxyProgesterone Market Share by Players in 2020
Figure 20. Global Top MedroxyProgesterone Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in MedroxyProgesterone as of 2020
Figure 21. The Top 10 and 5 Players Market Share by MedroxyProgesterone Revenue in 2020
Figure 22. Global MedroxyProgesterone Revenue Market Share by Type (2016-2021)
Figure 23. Global MedroxyProgesterone Revenue Market Share by Type (2022-2027)
Figure 24. North America MedroxyProgesterone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America MedroxyProgesterone Market Share by Type (2016-2027)
Figure 26. North America MedroxyProgesterone Market Share by Application (2016-2027)
Figure 27. North America MedroxyProgesterone Market Share by Country (2016-2027)
Figure 28. United States MedroxyProgesterone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada MedroxyProgesterone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe MedroxyProgesterone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe MedroxyProgesterone Market Share by Type (2016-2027)
Figure 32. Europe MedroxyProgesterone Market Share by Application (2016-2027)
Figure 33. Europe MedroxyProgesterone Market Share by Country (2016-2027)
Figure 34. Germany MedroxyProgesterone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France MedroxyProgesterone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. MedroxyProgesterone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy MedroxyProgesterone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia MedroxyProgesterone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic MedroxyProgesterone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific MedroxyProgesterone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific MedroxyProgesterone Market Share by Type (2016-2027)
Figure 42. Asia-Pacific MedroxyProgesterone Market Share by Application (2016-2027)
Figure 43. Asia-Pacific MedroxyProgesterone Market Share by Region (2016-2027)
Figure 44. China MedroxyProgesterone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan MedroxyProgesterone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea MedroxyProgesterone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia MedroxyProgesterone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India MedroxyProgesterone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia MedroxyProgesterone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America MedroxyProgesterone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America MedroxyProgesterone Market Share by Type (2016-2027)
Figure 52. Latin America MedroxyProgesterone Market Share by Application (2016-2027)
Figure 53. Latin America MedroxyProgesterone Market Share by Country (2016-2027)
Figure 54. Mexico MedroxyProgesterone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil MedroxyProgesterone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa MedroxyProgesterone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa MedroxyProgesterone Market Share by Type (2016-2027)
Figure 58. Middle East & Africa MedroxyProgesterone Market Share by Application (2016-2027)
Figure 59. Middle East & Africa MedroxyProgesterone Market Share by Country (2016-2027)
Figure 60. Turkey MedroxyProgesterone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia MedroxyProgesterone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE MedroxyProgesterone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Carlo Erba Revenue Growth Rate in MedroxyProgesterone Business (2016-2021)
Figure 64. Pfizer Revenue Growth Rate in MedroxyProgesterone Business (2016-2021)
Figure 65. Polichem Revenue Growth Rate in MedroxyProgesterone Business (2016-2021)
Figure 66. Nanjing Chengong Pharmaceutical Revenue Growth Rate in MedroxyProgesterone Business (2016-2021)
Figure 67. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Revenue Growth Rate in MedroxyProgesterone Business (2016-2021)
Figure 68. Beijing Yimin Pharmaceutical Revenue Growth Rate in MedroxyProgesterone Business (2016-2021)
Figure 69. Guangzhou Kanghe Pharmaceutical Revenue Growth Rate in MedroxyProgesterone Business (2016-2021)
Figure 70. Zhejiang Xianju Pharmaceutical Revenue Growth Rate in MedroxyProgesterone Business (2016-2021)
Figure 71. Beijing Kangbide Pharmaceutical Revenue Growth Rate in MedroxyProgesterone Business (2016-2021)
Figure 72. Harbin Outi Pharmaceutical Revenue Growth Rate in MedroxyProgesterone Business (2016-2021)
Figure 73. Hong Kong Aomei Pharmaceutical Factory Revenue Growth Rate in MedroxyProgesterone Business (2016-2021)
Figure 74. Jiangxi Zezhong Pharmaceutical Revenue Growth Rate in MedroxyProgesterone Business (2016-2021)
Figure 75. Nanjing Housheng Pharmaceutical Revenue Growth Rate in MedroxyProgesterone Business (2016-2021)
Figure 76. Yantai Luyin Pharmaceutical Revenue Growth Rate in MedroxyProgesterone Business (2016-2021)
Figure 77. Beijing Langyi Pharmaceutical Revenue Growth Rate in MedroxyProgesterone Business (2016-2021)
Figure 78. Sinopharm group Revenue Growth Rate in MedroxyProgesterone Business (2016-2021)
Figure 79. Chuankang Pharmaceutical Revenue Growth Rate in MedroxyProgesterone Business (2016-2021)
Figure 80. GMP Revenue Growth Rate in MedroxyProgesterone Business (2016-2021)
Figure 81. Hubei Gedian Renfu Pharmaceutical Revenue Growth Rate in MedroxyProgesterone Business (2016-2021)
Figure 82. Shanghai Xinhualian Pharmaceutical Revenue Growth Rate in MedroxyProgesterone Business (2016-2021)
Figure 83. China Resources Zizhu Pharmaceutical Revenue Growth Rate in MedroxyProgesterone Business (2016-2021)
Figure 84. Guangzhou Langsheng Pharmaceutical Revenue Growth Rate in MedroxyProgesterone Business (2016-2021)
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed
Companies
Carlo Erba
Pfizer
Polichem
Nanjing Chengong Pharmaceutical
Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
Beijing Yimin Pharmaceutical
Guangzhou Kanghe Pharmaceutical
Zhejiang Xianju Pharmaceutical
Beijing Kangbide Pharmaceutical
Harbin Outi Pharmaceutical
Hong Kong Aomei Pharmaceutical Factory
Jiangxi Zezhong Pharmaceutical
Nanjing Housheng Pharmaceutical
Yantai Luyin Pharmaceutical
Beijing Langyi Pharmaceutical
Sinopharm group
Chuankang Pharmaceutical
GMP
Hubei Gedian Renfu Pharmaceutical
Shanghai Xinhualian Pharmaceutical
China Resources Zizhu Pharmaceutical
Guangzhou Langsheng Pharmaceutical
- PRICE
-
$3900$7800$5850Buy Now